$0.12 1.1%
ZOM Stock Price vs. AI Score
Data gathered: November 7

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Zomedica

Zomedica is a veterinary health company focused on meeting the needs of clinical veterinarians in ways that promote both patient and practice health.


Zomedica
Price $0.12
Target Price Sign up
Volume 1,450,000
Market Cap $120M
Year Range $0.12 - $0.18
Dividend Yield 0%
Analyst Rating 0% buy
Earnings Date November 7 '24
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '246.1M1.8M4.4M-24M-23M-0.024
Q1 '246.3M2.1M4.1M-9.2M-8.8M-0.010
Q4 '237.3M2.3M5.1M-22M-20M-0.010
Q3 '236.3M2M4.4M-490,000-950,000-0.001
Q2 '236M2M4M-5.2M-4M-0.010

Insider Transactions View All

HEATON LARRY C II filed to buy 400,000 shares at $0.1.
September 5 '24
POWERS JOHNNY D filed to buy 2,325,000 shares at $0.1.
August 28 '24
Blair Anthony K filed to buy 250,000 shares at $0.1.
August 20 '24
Klass Russell Kevin filed to buy 2,000,050 shares at $0.2.
June 13 '24
Klass Russell Kevin filed to buy 1,700,057 shares at $0.2.
June 12 '24

What is the Market Cap of Zomedica?

The Market Cap of Zomedica is $120M.

When does Zomedica report earnings?

Zomedica will report its next earnings on November 7 '24.

What is the current stock price of Zomedica?

Currently, the price of one share of Zomedica stock is $0.12.

How can I analyze the ZOM stock price chart for investment decisions?

The ZOM stock price chart above provides a comprehensive visual representation of Zomedica's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zomedica shares. Our platform offers an up-to-date ZOM stock price chart, along with technical data analysis and alternative data insights.

Does ZOM offer dividends to its shareholders?

As of our latest update, Zomedica (ZOM) does not offer dividends to its shareholders. Investors interested in Zomedica should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Zomedica?

Some of the similar stocks of Zomedica are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.